Investigators propose to conduct a pilot single-blind, parallel arm, randomized placebo-controlled trial evaluating the feasibility, acceptability, and preliminary efficacy of bright light therapy on reward system functioning among patients undergoing medication-assisted treatment for opioid use disorder.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Feasibility--drop-out rate
Timeframe: At 2 weeks post-treatment
Feasibility--adherence to intervention
Timeframe: At 2 weeks post-treatment
Acceptability of the intervention
Timeframe: At 2 weeks post-treatment
Changes in reward learning
Timeframe: Baseline and 2 weeks post-treatment
Changes in reward valuation
Timeframe: Baseline and 2 weeks post-treatment
Changes in Opioid Craving
Timeframe: Daily for the 1 week at baseline and throughout the treatment period (up to 2 weeks)